High-tech rehabilitation program for adults with acute neuromuscular disease
Official title: Clinical Protocol for a Pragmatic Trial on a High-Tech Rehabilitation Pathway for Acute Adult Neuromuscular Diseases (Fit4MedRob-Acute MND Project)
Run by Istituti Clinici Scientifici Maugeri SpA · NCT06822231 · Data updated 2026-11-12
This trial will test whether a high-tech rehab program using robotics, virtual reality, and balance platforms helps adults with acute neuromuscular conditions improve balance, strength, fatigue, and quality of life more than usual therapy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 124 (estimated) |
| Sponsor | Istituti Clinici Scientifici Maugeri SpA Academic / other |
| Locations | 8 sites (Bari and 7 other locations) |
| Status | Recruiting |
| Started | May 28, 2025 |
| Main results expected | May 2027 |
| Study ends | June 2027 |
| Registry record updated | November 4, 2026 |
| Trial ID | NCT06822231 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–80 with a confirmed acute/subacute neuromuscular diagnosis (GBS, CIM, CIP) within 15–30 days of onset, with at least MRC ≥2 in two lower-limb muscle groups and able to give informed consent are ideal candidates.
✕Probably not a fit
Patients with unstable medical conditions (for example NYHA class IV heart failure), uncompensated respiratory failure, very low lower-limb strength (MRC <2), pregnant or breastfeeding women, or those enrolled in conflicting trials are unlikely to be eligible or to benefit from the protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, parallel-assignment study compares a high-tech rehabilitation circuit (robotic systems, virtual reality, stabilometric platforms) to conventional rehabilitation in adults with acute/subacute neuromuscular diseases such as Guillain-Barré syndrome, critical illness myopathy, and critical illness polyneuromyopathy. Participants aged 18–80 within 15–30 days of symptom onset and with minimum preserved lower-limb strength will be randomized to receive either the advanced-technology protocol or standard care. The protocol emphasizes intensive, rapid rehabilitation with repeated, standardized sessions delivered by multidisciplinary teams and uses the Berg Balance Scale and other motor, fatigue, sarcopenia, cognitive engagement, and quality-of-life measures as outcomes. The primary outcome is a predefined improvement in balance (at least 10 points on the Berg Balance Scale) from baseline to end of treatment.
Why it matters
Potential benefit: If successful, this program could speed and enhance recovery of balance, strength, and daily function compared with standard rehabilitation for patients with acute neuromuscular diseases.
How similar studies have gone: Related robotic and virtual-reality rehabilitation approaches have shown benefits in stroke and chronic neuromuscular rehabilitation, but rigorous randomized evidence specifically in acute neuromuscular diseases is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults with ages ranging from 18 to 80 years. * Patients with a confirmed diagnosis of acute/subacute neuromuscular diseases (e.g. GBS, CIM, CIP) * Time of onset ranging from 15 to 30 days * Patients with lower limb strength (Medical Research Council or MRC) \>=2 in at least two of the flexor and extensor muscles of the following joints: hip, knee and ankle * Possibility of obtaining informed consent Exclusion Criteria: * Patients with unstable medical conditions (e.g. severe cardiovascular diseases, such as "New York Heart Association" - NYHA=4, respiratory distress not compensated by ventilation) that could interfere, in the clinician's judgment, with their ability to safely participate in the study or to perform the assessments related to the protocol. * Patients currently participating in other clinical trials that could interfere with this study. * Pregnant or breastfeeding women.
Where it's running
-
Istituti Clinici Scientifici Maugeri IRCCS, Milan Institute
Milan, Italy Recruiting -
Istituti Clinici Scientifici Maugeri
Bari, Italy Not yet recruiting -
IRCCS Azienda Ospedaliera Universitaria San Martino - Genova
Genova, Italy Not yet recruiting -
Azienda Ospedaliero-Universitaria di Modena
Modena, Italy Not yet recruiting -
Istituti Clinici Scientifici Maugeri
Montescano, Italy Not yet recruiting -
Istituti Clinici Scientifici Maugeri
Pavia, Italy Not yet recruiting
Show 2 more locations
-
Fondazione Don Carlo Gnocchi Onlus
Roma, Italy Not yet recruiting -
Istituti Clinici Scientifici Maugeri
Telese Terme, Italy Not yet recruiting
Study contacts
- Study coordinator: Christian Lunetta, MD
- Email: christian.lunetta@icsmaugeri.it
- Phone: +39 0250725266
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Critical-illness–related muscle and nerve weakness in adults hospitalized outside the ICU
This project will test how often adults hospitalized with acute illness outside the ICU develop severe muscle and nerve weakness by comparing patients with organ failure to those without.
-
Physical therapy and NLRP3-related ICU-acquired muscle weakness
This study will test whether enhanced physical therapy using servo-assisted bed cycling can reduce NLRP3 inflammasome activation and muscle wasting in critically ill patients at risk of critical illness myopathy.
-
Exploring the experiences of children who had Guillain-Barré Syndrome.
This study is trying to learn about the feelings and experiences of children who had Guillain-Barré Syndrome a few years ago to better understand how it affects their lives.
-
Improving walking recovery in patients with muscle weakness from critical illness
This study is testing if using electrical stimulation during rehabilitation can help critically ill patients with muscle weakness walk better and recover faster.
-
Using ultrasound to improve diagnosis of nerve disorders like GBS and CIDP
This study is testing if using ultrasound can help doctors better diagnose nerve disorders like Guillain-Barré Syndrome and CIDP by comparing ultrasound results with other nerve tests.
-
Study on muscle weakness after surgery in intensive care patients
This study is testing if changes in blood and muscle samples from surgical patients can help us understand and find markers for muscle weakness that happens after being in intensive care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.